Multicohort phase 2 study of pembrolizumab for relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Keynote-087 Meeting Abstract

   


Authors: Moskowitz, C.; Zinzani, P. L.; Fanale, M. A.; Armand, P.; Johnson, N.; Ribrag, V.; Radford, J.; von Tresckow, B.; Tomita, A.; Shipp, M. A.; Wang, Y.; Ricart, A. D.; Balakumaran, A.; Chen, R.
Abstract Title: Multicohort phase 2 study of pembrolizumab for relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Keynote-087
Meeting Title: 21st Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 101
Issue: Suppl. 1
Meeting Dates: 2016 Jun 9-12
Meeting Location: Copenhagen, Denmark
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2016-06-01
Start Page: 319
Language: English
ACCESSION: WOS:000379484601156
PROVIDER: wos
PMCID: PMC4894295
Notes: Meeting Abstract: S794 -- Source: Wos